A new trading day began on Tuesday, with IGC Pharma Inc (AMEX: IGC) stock price down -4.98% from the previous day of trading, before settling in for the closing price of $0.3. IGC’s price has ranged from $0.25 to $0.50 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 12.85%. Meanwhile, its annual earnings per share averaged 11.11%. With a float of $71.51 million, this company’s outstanding shares have now reached $91.96 million.
IGC Pharma Inc (IGC) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of IGC Pharma Inc is 23.00%, while institutional ownership is 5.86%.
IGC Pharma Inc (IGC) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.02 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.11% per share during the next fiscal year.
IGC Pharma Inc (AMEX: IGC) Trading Performance Indicators
Here are IGC Pharma Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 23.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.08, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach -0.09 in one year’s time.
Technical Analysis of IGC Pharma Inc (IGC)
The latest stats from [IGC Pharma Inc, IGC] show that its last 5-days average volume of 0.54 million was inferior to 1.14 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 10.32%.
During the past 100 days, IGC Pharma Inc’s (IGC) raw stochastic average was set at 2.39%, which indicates a significant decrease from 6.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0262 in the past 14 days, which was higher than the 0.0249 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3446, while its 200-day Moving Average is $0.3444. Now, the first resistance to watch is $0.2946. This is followed by the second major resistance level at $0.3067. The third major resistance level sits at $0.3154. If the price goes on to break the first support level at $0.2738, it is likely to go to the next support level at $0.2651. Assuming the price breaks the second support level, the third support level stands at $0.2530.
IGC Pharma Inc (AMEX: IGC) Key Stats
With a market capitalization of 26.24 million, the company has a total of 92,868K Shares Outstanding. Currently, annual sales are 1,270 K while annual income is -7,120 K. The company’s previous quarter sales were 190 K while its latest quarter income was -1,820 K.
